Dipartimento delle Terapie Oncologiche Integrate, IRCCS AOU San Martino-IST, Genoa, Italy.
Dipartimento di Ricerca e Diagnostica, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
Eur J Immunol. 2017 Jun;47(6):1051-1061. doi: 10.1002/eji.201646885. Epub 2017 May 5.
X-linked lymphoproliferative disease 1 (XLP1) is an inherited immunodeficiency, caused by mutations in SH2D1A encoding Signaling Lymphocyte Activation Molecule (SLAM)-associated protein (SAP). In XLP1, 2B4, upon engagement with CD48, has inhibitory instead of activating function. This causes a selective inability of cytotoxic effectors to kill EBV-infected cells, with dramatic clinical sequelae. Here, we investigated the NK cell education in XLP1, upon characterization of killer Ig-like receptor (KIR)/KIR-L genotype and phenotypic repertoire of self-HLA class I specific inhibitory NK receptors (self-iNKRs). We also analyzed NK-cell cytotoxicity against CD48 or CD48 KIR-ligand matched or autologous hematopoietic cells in XLP1 patients and healthy controls. XLP1 NK cells may show a defective phenotypic repertoire with substantial proportion of cells lacking self-iNKR. These NK cells are cytotoxic and the inhibitory 2B4/CD48 pathway plays a major role to prevent killing of CD48 EBV-transformed B cells and M1 macrophages. Importantly, self-iNKR defective NK cells kill CD48 targets, such as mature DCs. Self-iNKR NK cells in XLP1 patients are functional even in resting conditions, suggesting a role of the inhibitory 2B4/CD48 pathway in the education process during NK-cell maturation. Killing of autologous mature DC by self-iNKR defective XLP1 NK cells may impair adaptive responses, further exacerbating the patients' immune defect.
X 连锁淋巴组织增生性疾病 1 型(XLP1)是一种遗传性免疫缺陷病,由编码信号淋巴细胞激活分子(SLAM)相关蛋白(SAP)的 SH2D1A 基因突变引起。在 XLP1 中,2B4 与 CD48 结合后具有抑制而非激活功能。这导致细胞毒性效应物选择性地无法杀死 EBV 感染的细胞,从而产生显著的临床后果。在这里,我们研究了 XLP1 中 NK 细胞的教育,方法是表征杀手 Ig 样受体(KIR)/KIR-L 基因型和自身 HLA Ⅰ类特异性抑制性 NK 受体(自身-iNKRs)的表型谱。我们还分析了 XLP1 患者和健康对照者中针对 CD48 或 CD48 KIR 配体匹配或自体造血细胞的 NK 细胞的细胞毒性。XLP1 NK 细胞可能表现出缺陷的表型谱,其中相当一部分细胞缺乏自身-iNKR。这些 NK 细胞具有细胞毒性,抑制性 2B4/CD48 途径在防止杀伤 CD48 EBV 转化的 B 细胞和 M1 巨噬细胞方面起着主要作用。重要的是,自身-iNKR 缺陷的 NK 细胞可杀伤 CD48 靶标,如成熟的 DC。XLP1 患者的自身-iNKR NK 细胞即使在静息状态下也具有功能,这表明抑制性 2B4/CD48 途径在 NK 细胞成熟过程中的教育过程中发挥作用。自身-iNKR 缺陷的 XLP1 NK 细胞杀伤自体成熟 DC 可能会损害适应性反应,进一步加剧患者的免疫缺陷。